Search Within

MSK Grad Students

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (362)
  2. Meeting Abstract (346)
  3. Research Letter (9)
  4. Miscellaneous (8)
  5. Conference Paper (3)
  6. Review (3)
  7. Correspondence (2)
  8. Editorial (2)
Groups
  1. Epidemiology and Biostatistics (735)
  2. Department of Medicine (619)
  3. Biostatistics Service (537)
  4. GSK Faculty (503)
  5. CTCR Scholars (468)
  6. Master of Science in Clinical and Translational Cancer Research (454)

More Groups

People
  1. Sean Devlin (277)
  2. Sergio Giralt (251)
  3. Miguel-Angel Perales (244)
  4. Parastoo Dahi (172)
  5. Doris Ponce (151)
  6. Nikolaus Schultz (148)

More People

Years
  1. 2025 (29)
  2. 2024 (86)
  3. 2023 (92)
  4. 2022 (102)
  5. 2021 (69)
  6. 2020 (98)

More Years

Publications
  1. Blood (120)
  2. Biology of Blood and Marrow Transplantation (86)
  3. Journal of Clinical Oncology (61)
  4. Annals of Surgical Oncology (41)
  5. Bone Marrow Transplantation (37)
  6. Cancer Research (33)

More Publications

Publishers
  1. American Society of Hematology (139)
  2. Elsevier Inc. (121)
  3. Nature Publishing Group (120)
  4. American Association for Cancer Research (77)
  5. American Society of Clinical Oncology (68)
  6. Springer (44)

More Publishers

Results (735)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic footprints of activated telomere maintenance mechanisms in cancer
    Journal Article

    Sieverling, L.; Hong, C.; Koser, S. D.; Ginsbach, P.; Kleinheinz, K.; Hutter, B.; Braun, D. M.; Cortés-Ciriano, I.; Xi, R.; Kabbe, R.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
    Journal Article

    Jiao, W.; Atwal, G.; Polak, P.; Karlic, R.; Cuppen, E.; Danyi, A.; de Ridder, J.; van Herpen, C.; Lolkema, M. P.; Steeghs, N.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • The tumor associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B-cell lymphoma
    Meeting Abstract

    Takata, K.; Chong, L. C.; Ennishi, D.; Thakur, A.; Healy, S.; Viganò, E.; Dao, T.; Nielsen, J. S.; Ben-Neriah, S.; Aoki, T.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical outcomes of acute myeloid leukemia patients bridged to allogeneic stem cell transplant by venetoclax combination therapy
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; Barker, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • A pilot study evaluating lenalidomide and CC-486 in combination with radiotherapy for patients with plasmacytoma (LENAZART study)
    Meeting Abstract

    Shah, U. A.; Werner, K.; Tavitian, E.; Devlin, S.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Tan, C.; Lu, S. X.; Smith, E. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Secondary graft-versus-host disease (GVHD) prophylaxis with oral proteasome inhibitor ixazomib is associated with low incidence of recurrent, late acute and chronic GVHD and facilitated calcineurin inhibitor taper within the first year post allogeneic stem cell transplantation
    Meeting Abstract

    Rodriguez, N.; Lee, J.; Flynn, L.; Murray, F.; Devlin, S.; Izquierdo, C. S.; Cho, C.; Dahi, P. B.; Giralt, S. A.; Sauter, C. S.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Favorable outcomes among patients with T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era
    Meeting Abstract

    Robin, E. T.; Drill, E.; Batlevi, C. L.; Caron, P.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; Joffe, E.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Rabbit anti-thymocyte globulin exposure (rATG) in CD34+ selected hematopoietic cell transplantation and its impact on immune reconstitution and outcomes in children and adults
    Meeting Abstract

    Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Jakubowski, A. A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Interim analysis from a prospective multicenter study of next-generation sequencing minimal residual disease assessment and CT monitoring for surveillance after frontline treatment in diffuse large B-cell lymphoma
    Meeting Abstract

    Kumar, A.; Westin, J.; Schuster, S. J.; Nowakowski, G. S.; Lossos, I. S.; Batlevi, C. L.; Caron, P.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clinical impact of bridging therapy prior to commercial chimeric antigen receptor (CAR) T-cell therapies for relapsed/refractory lymphomas
    Meeting Abstract

    Imber, B. S.; Perales, M. A.; Flynn, J.; Ruiz, J. D.; Devlin, S.; Alarcon Tomas, A.; Hajj, C.; Batlevi, C. L.; Dahi, P. B.; Lin, R. J.; more...
    Blood (2020)

    Fulltext@MSK | Save